SOC status:Duty analyst on shift

UK Cyber Defence
VulnerabilityModified

CVE-2014-5406

The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via…

HIGH 9.3EPSS 1.24%

Does this matter?

High impact if exploited, but EPSS currently rates exploitation as unlikely (1.24%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.

Description

The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.

CVSS 2.0
9.3 HIGHAV:N/AC:M/Au:N/C:C/I:C/A:C
EPSS
1.24% probability · 68th percentile
CISA KEV
Not listed
Weakness
CWE-345
Affected
hospira/lifecare pcainfusion firmware
Source
ics-cert@hq.dhs.gov

Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.